Get the Stockscreener App
3.275
1.87%
0.065
Mdxhealth Sa stock is traded at $3.275, with a volume of 8,706.
It is up +1.87% in the last 24 hours and down -9.17% over the past month.
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.
See More
Previous Close:
$3.21
Open:
$3.22
24h Volume:
8,706
Relative Volume:
0.05
Market Cap:
$165.91M
Revenue:
$63.69M
Net Income/Loss:
$-44.82M
P/E Ratio:
-1.6375
EPS:
-2
Net Cash Flow:
$-30.56M
1W Performance:
-8.40%
1M Performance:
-9.17%
6M Performance:
+52.80%
1Y Performance:
+48.64%
1-Day Range:
$3.22
$3.34
1-Week Range:
$3.20
$3.60
52-Week Range:
$1.35
$5.33
Mdxhealth Sa Stock (MDXH) Company Profile
Compare MDXH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDXH
Mdxhealth Sa
|
3.23 | 164.88M | 63.69M | -44.82M | -30.56M | -2.00 |
|
TMO
Thermo Fisher Scientific Inc
|
620.54 | 233.21B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
235.67 | 167.12B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
716.97 | 56.44B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
147.54 | 41.84B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
243.94 | 40.96B | 15.90B | 1.28B | 2.21B | 7.2842 |
Mdxhealth Sa Stock (MDXH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-17-25 | Initiated | Craig Hallum | Buy |
| Oct-31-24 | Initiated | Lake Street | Buy |
| May-31-23 | Initiated | TD Cowen | Outperform |
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
Mdxhealth Sa Stock (MDXH) Latest News
MDxHealth announces next phase of collab with University of Oxford - TipRanks
Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer - The Manila Times
World’s largest prostate cancer trial adds genomic test to guide care - Stock Titan
MDxHealth SA (NASDAQ:MDXH) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
MDxHealth SA (NASDAQ:MDXH) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
MDxHealth Files to Sell Up to $200 Million in Shares - marketscreener.com
MDxHealth SA to offer securities up to $200 millionSEC filing - marketscreener.com
MDxHealth SA (NASDAQ:MDXH) Short Interest Update - MarketBeat
Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), MDxHealth (MDXH) and RxSight (RXST) - The Globe and Mail
MDXH: BTIG Reiterates Buy Rating with $7 Price Target | MDXH Sto - GuruFocus
BTIG reiterates Buy rating on MDxHealth stock, maintains $7 price target By Investing.com - Investing.com South Africa
BTIG Research Reaffirms "Buy" Rating for MDxHealth (NASDAQ:MDXH) - MarketBeat
BTIG reiterates Buy rating on MDxHealth stock, maintains $7 price target - Investing.com Australia
How MDxHealth SA stock benefits from tech adoptionMarket Sentiment Review & Capital Efficient Trading Techniques - Улправда
Why MDxHealth SA stock remains undervalued2025 Valuation Update & Weekly Watchlist for Consistent Profits - Улправда
Is MDxHealth SA stock overvalued by current metricsJuly 2025 Setups & Advanced Technical Signal Analysis - Улправда
Retail Surge: How MDxHealth SA stock benefits from tech adoptionJuly 2025 Intraday Action & Weekly Setup with ROI Potential - Улправда
How MDxHealth SA stock reacts to inflationary pressuresPortfolio Gains Summary & Stepwise Trade Execution Plans - bolumsonucanavari.com
Why MDxHealth SA stock is a must watch in 20252025 Growth vs Value & AI Powered Market Entry Ideas - DonanımHaber
Can MDxHealth SA stock resist sector downturnsQuarterly Investment Review & Stock Portfolio Risk Control - Улправда
Reviewing 111 (NASDAQ:YI) & MDxHealth (NASDAQ:MDXH) - Defense World
MDxHealth SA (NASDAQ:MDXH) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
MDxHealth management to meet virtually with BTIG - MSN
MDxHealth price target raised to $7 from $5 at TD Cowen - MSN
MDXH: Upcoming Virtual Meeting Hosted by BTIG - GuruFocus
Samjo Management LLC Sells 96,718 Shares of MDxHealth SA $MDXH - MarketBeat
MDxHealth SA (NASDAQ:MDXH) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough - simplywall.st
MDxHealth SA's (NASDAQ:MDXH) market cap touched US$182m last week, benefiting both individual investors who own 46% as well as institutions - simplywall.st
Institutions profited after MDxHealth SA's (NASDAQ:MDXH) market cap rose US$17m last week but retail investors profited the most - Yahoo Finance
123,546 Shares in MDxHealth SA $MDXH Purchased by FreeGulliver LLC - MarketBeat
Is MDxHealth SA a good long term investmentEarnings Per Share Trends & Free Robust Financial Gains - earlytimes.in
How MDxHealth SA stock reacts to global recession fearsJuly 2025 Short Interest & Fast Entry and Exit Trade Plans - newser.com
Will MDxHealth SA stock rally after Fed decisions2025 Short Interest & Growth Focused Entry Point Reports - newser.com
MDxHealth (MDXH) Q3 2025 Earnings Call Transcript - AOL.com
What does recent volatility data suggest for MDxHealth SAWeekly Risk Summary & Reliable Volume Spike Trade Alerts - newser.com
Live market analysis of MDxHealth SA2025 Retail Activity & Low Risk Entry Point Tips - newser.com
How MDxHealth SA stock benefits from global expansionBull Run & Growth-Oriented Investment Plans - newser.com
How to monitor MDxHealth SA with trend dashboardsJuly 2025 Highlights & Risk Managed Investment Strategies - newser.com
Will MDxHealth SA stock deliver strong dividend growthChart Signals & Entry Point Confirmation Alerts - newser.com
FY2025 EPS Estimates for MDxHealth Reduced by William Blair - Defense World
OC500 2025: MICHAEL MCGARRITY - Orange County Business Journal
Volume spikes in MDxHealth SA stock – what they meanJuly 2025 Breakouts & Fast Gain Swing Alerts - newser.com
Market reaction to MDxHealth SA’s recent news2025 Market WrapUp & Free Technical Confirmation Trade Alerts - newser.com
MDxHealth (NASDAQ:MDXH) Price Target Raised to $7.00 - Defense World
MDxHealth price target raised to $7 from $6 at BTIG - MSN
Mdxhealth Sa Stock (MDXH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.14%
0.67%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):